SCHEMBL24478481

SCHEMBL24478481

CN(C)S(=O)(=O)c1cccc(C(=O)O)c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.50
CASP7 P55210 2/20 0.49
ALOX15 P16050 2/20 0.49
G6PD P11413 1/20 0.49
CASP6 P55212 1/20 0.49
ALDH1A1 P00352 4/20 0.41
F2 P00734 3/20 0.41
PRSS1 P07477 3/20 0.41
PRSS2 P07478 3/20 0.41
PRSS3 P35030 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MMP2 P08253 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MMP1 P03956 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
HTT P42858 1/20 0.40
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5515234 0.82 MCL1 (0.59) MCL1ALOX15ALDH1A1F2PRSS1
SCHEMBL29385278 0.82 MCL1 (0.59) MCL1ALOX15ALDH1A1F2PRSS1
SCHEMBL10678326 0.81 MCL1 (0.51) MCL1CASP7ALOX15ALDH1A1F2
SCHEMBL29467302 0.81 MCL1 (0.59) MCL1CASP7ALOX15ALDH1A1F2
SCHEMBL7707773 0.80 G6PD (0.57) CASP7ALOX15G6PDCASP6ALDH1A1
SCHEMBL11174948 0.80 MCL1 (0.50) MCL1CASP7ALOX15ALDH1A1F2
SCHEMBL524233 0.79 CASP7 (0.55) CASP7ALOX15G6PDCASP6ALDH1A1
SCHEMBL3951462 0.79 G6PD (0.60) MCL1CASP7ALOX15G6PDCASP6
SCHEMBL6457388 0.78 G6PD (0.55) CASP7ALOX15G6PDCASP6ALDH1A1
SCHEMBL5490712 0.78 CASP7 (0.50) CASP7ALOX15G6PDCASP6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025880-A1 AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-01-25 US disclosed
US-20240025880-A1 AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-01-25 US disclosed
WO-2022112490-A1 AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025880-A1 AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS P2RX3, P2RX5, P2RX1 MCL1 4749/4885CASP7 4171/4885ALOX15 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.